Disease Characteristics and Burden in Patients With Atopic Dermatitis: Insights From Two Phase 3 Studies of Ruxolitinib Cream

被引:0
|
作者
Simpson, Eric [1 ]
Lee, Mark [2 ]
Brar, Kanwaljit [3 ]
Kuligowski, Michael [4 ]
Venturanza, May [4 ]
Sun, Kang [4 ]
Toth, Darryl [5 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Progress Clin Res, San Antonio, TX USA
[3] NYU, Grossman Sch Med, Hassenfeld Childrens Hosp, New York, NY USA
[4] Incyte Corp, Wilmington, DE USA
[5] XLR8 Med Res & Prob Med Res, Windsor, ON, Canada
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
108
引用
收藏
页码:AB35 / AB35
页数:1
相关论文
共 50 条
  • [41] Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial
    Fuxench, Zelma C. Chiesa
    Lai, Zhihong
    Kuo, Yutzu
    Nawaz, Haq
    Cotliar, Jonathan
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [42] Predicting reduction in lost productivity and indirect costs in patients with atopic dermatitis treated with ruxolitinib cream
    Bloudek, L.
    Eichenfield, L. F.
    Silverberg, J. I.
    Joish, Vijay N.
    Kuligowski, M. E.
    Lofland, J. H.
    Migliaccio-Walle, K.
    Sullivan, S. D.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E144 - E145
  • [43] Tapinarof cream for the treatment of atopic dermatitis: Efficacy and safety results from two Japanese phase 3 trials
    Igarashi, Atsuyuki
    Tsuji, Gaku
    Fukasawa, Shuichi
    Murata, Ryusei
    Yamane, Satoshi
    JOURNAL OF DERMATOLOGY, 2024, 51 (11): : 1404 - 1413
  • [44] TAPINAROF CREAM IMPROVED ITCH IN TWO PHASE 3 TRIALS OF MODERATE TO SEVERE ATOPIC DERMATITIS
    Silverberg, J.
    Boguniewicz, M.
    Rubenstein, D.
    Tallman, A.
    Brown, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S90 - S90
  • [45] The disease burden of pediatric patients with atopic dermatitis in Japan
    Ohya, Yukihiro
    Saeki, Hidehisa
    Nawata, Hisakatsu
    Arima, Kazuhiko
    Inukai, Miho
    Rossi, Ana B.
    Le-Bagousse-Bego, Gaelle
    PEDIATRIC DERMATOLOGY, 2023, : 851 - 856
  • [46] Exacerbating factors and disease burden in patients with atopic dermatitis
    Murota, Hiroyuki
    Koike, Yuta
    Morisaki, Hitomi
    Matsumoto, Mai
    Takenaka, Motoi
    ALLERGOLOGY INTERNATIONAL, 2022, 71 (01) : 25 - 30
  • [47] Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies
    Simpson, Eric L.
    Augustin, Matthias
    Thaci, Diamant
    Misery, Laurent
    Armstrong, April W.
    Blauvelt, Andrew
    Papp, Kim A.
    Szepietowski, Jacek C.
    Boguniewicz, Mark
    Kwatra, Shawn G.
    Kallender, Howard
    Sturm, Daniel
    Ren, Haobo
    Kircik, Leon
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2025, 26 (01) : 121 - 137
  • [48] Effects of ruxolitinib cream on sleep and quality of life over 52 weeks in black patients with atopic dermatitis
    Eichenfield, L. F.
    Gold, L. F. Stein
    Brar, K. K.
    Fuxench, Z. C. Chiesa
    Silverberg, J. I.
    Venturanza, M. E.
    Kallender, H.
    Gao, J.
    Simpson, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S47 - S47
  • [49] Ruxolitinib cream provided progressive improvement in patients with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success at week 8: Pooled results from 2 phase 3 studies
    Eichenfield, Lawrence F.
    Blauvelt, Andrew
    Kircik, Leon
    Venturanza, May E.
    Ren, Haobo
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB202 - AB202
  • [50] Effect of ruxolitinib cream on sleep disturbance and sleep impairment: Pooled analysis from two randomized phase 3 studies
    Simpson, Eric L.
    Boguniewicz, Mark
    Thaci, Diamant
    Misery, Laurent
    Silverberg, Jonathan I.
    Beck, Lisa A.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Szepietowski, Jacek C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB121 - AB121